Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
Kalkine Media ASX Share Market News & Research

Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Dell (NYSE:DELL) Stock Keeps AI Valuation Debate Alive
Technology Stocks

Dell (NYSE:DELL) Stock Keeps AI Valuation Debate Alive

AI infrastructure expansion, enterprise technology demand, and favorable valuation models continue shaping the long-term outlook while execution and innovation remain important factors for future business performance.

Can Caterpillar (NYSE:CAT) Power Its Next Growth Cycle?
Industrial Stocks

Can Caterpillar (NYSE:CAT) Power Its Next Growth Cycle?

Caterpillar’s expanding exposure to infrastructure, power generation, defense, construction, and data centers strengthens its outlook, while tariffs, execution demands, and economic uncertainty continue shaping expectations around future performance.

Pfizer (NYSE:PFE) Oncology Growth Faces A Major Valuation Test
Healthcare Stocks

Pfizer (NYSE:PFE) Oncology Growth Faces A Major Valuation Test

Pfizer’s oncology progress supports its pipeline narrative, while balanced valuation, patent pressure, weight-management research, and commercialization demands shape the company’s next phase of earnings development.

UnitedHealth Group (NYSE:UNH): Is the Recovery Fully Priced In?
Healthcare Stocks

UnitedHealth Group (NYSE:UNH): Is the Recovery Fully Priced In?

UnitedHealth’s improving forecasts strengthen its recovery outlook, while regulatory scrutiny, medical expenses, and margin execution will determine whether its current valuation remains supported through the next phase.

Johnson & Johnson (NYSE:JNJ): Can Fundamentals Support Its Valuation?
Healthcare Stocks

Johnson & Johnson (NYSE:JNJ): Can Fundamentals Support Its Valuation?

Strong cash generation and diversified healthcare operations support the valuation outlook, while balanced earnings measures, legal uncertainty, competitive pressure, and research execution keep the broader market assessment divided.

Salesforce (NYSE:CRM) Faces A Critical Security Test
Technology Stocks

Salesforce (NYSE:CRM) Faces A Critical Security Test

Fresh security guidance highlights access controls, configuration risks, monitoring, compliance, and recovery planning as enterprises reassess cloud safeguards and the operational resilience of data-driven platforms.

Bloom Energy (NYSE:BE) Faces AI Deal Test After Major Power Expansion
Industrial Stocks

Bloom Energy (NYSE:BE) Faces AI Deal Test After Major Power Expansion

Artificial intelligence infrastructure continues driving demand for advanced energy solutions, with innovation, execution, financing, and scalable deployment remaining central themes shaping future industry development.

Can Arista Networks (NYSE:ANET) AI Security Expansion Support Its Valuation?
Technology Stocks

Can Arista Networks (NYSE:ANET) AI Security Expansion Support Its Valuation?

Arista Networks is expanding artificial intelligence security beyond data centers, while Ethernet demand supports growth and premium valuation expectations increase pressure for consistent execution across its broader networking platform.

Abbott (NYSE:ABT) Faces A Crucial Valuation Test
Healthcare Stocks

Abbott (NYSE:ABT) Faces A Crucial Valuation Test

Abbott’s valuation outlook is strengthening as legal uncertainty fades, while medical devices, diagnostics, diversified operations, and cash generation provide support despite continuing regulatory, pricing, and execution risks.

Can Cummins (NYSE:CMI) Sustain Its Dividend Momentum?
Industrial Stocks

Can Cummins (NYSE:CMI) Sustain Its Dividend Momentum?

Cummins is balancing stronger income returns with power-system expansion, cleaner technology investment, and truck-market pressure, making cash-flow durability and disciplined execution central to its evolving long-term business narrative.